Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 2 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

2 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Jan. 14, 2019 ARWR S 10b5-1 40,500 $14.34 $580,770 201,700 Direct -16.72% Disposed 342.7% (price as of 2026-10-05)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Sept. 24, 2026 ADRX Employee Stock Option (right to buy) Common Stock (1,024,152) $17.00 Sept. 23, 2036 1,024,152 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 22 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
Sept. 24, 2026 ADRX Common Stock 5,861,199 Indirect
Sept. 24, 2026 ADRX Employee Stock Option (right to buy)→ Common Stock (1,171,325) 1,171,325 Direct
Sept. 24, 2026 ADRX Employee Stock Option (right to buy)→ Common Stock (327,378) 327,378 Direct
Sept. 24, 2026 ADRX Employee Stock Option (right to buy)→ Common Stock (320,500) 320,500 Direct
Sept. 24, 2026 ADRX Employee Stock Option (right to buy)→ Common Stock (845,726) 845,726 Direct
Sept. 24, 2026 ADRX Employee Stock Option (right to buy)→ Common Stock (710,541) 710,541 Direct
Sept. 24, 2026 ADRX Employee Stock Option (right to buy)→ Common Stock (436,715) 436,715 Direct
Sept. 24, 2026 ADRX Employee Stock Option (right to buy)→ Common Stock (436,715) 436,715 Direct
Sept. 24, 2026 ADRX Employee Stock Option (right to buy)→ Common Stock (773,085) 773,085 Direct
Sept. 24, 2026 ADRX Employee Stock Option (right to buy)→ Common Stock (426,730) 426,730 Direct
Sept. 24, 2026 ADRX Employee Stock Option (right to buy)→ Common Stock (443,799) 443,799 Direct
Sept. 24, 2026 ADRX Employee Stock Option (right to buy)→ Common Stock (17,069) 17,069 Indirect
Sept. 24, 2026 ADRX Employee Stock Option (right to buy)→ Common Stock (12,801) 12,801 Indirect
Sept. 24, 2026 ADRX Employee Stock Option (right to buy)→ Common Stock (8,534) 8,534 Indirect
Sept. 24, 2026 ADRX Employee Stock Option (right to buy)→ Common Stock (6,827) 6,827 Indirect
Sept. 24, 2026 ADRX Employee Stock Option (right to buy)→ Common Stock (5,120) 5,120 Indirect
Sept. 24, 2026 ADRX Employee Stock Option (right to buy)→ Common Stock (5,120) 5,120 Indirect
Sept. 24, 2026 ADRX Employee Stock Option (right to buy)→ Common Stock (12,801) 12,801 Indirect
Jan. 29, 2018 ARWR Common Stock · Direct
Jan. 29, 2018 ARWR Stock Option→ Common Stock (60,000) 60,000 Direct
Jan. 29, 2018 ARWR Stock Option→ Common Stock (47,500) 47,500 Direct
Jan. 29, 2018 ARWR Stock Option→ Common Stock (50,000) 50,000 Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

ARWR

President, Chemistry and Non-Clinical Development
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2017 $247,448 · · · $120,000 · $6,798 $505,996
2016 $237,930 · · · $72,072 · $10,173 $550,654

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.